Peng Liu

3PUBLICATIONS
3CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Aug 11, 2026
PROTAC-Engineered Protein/DNA Nanoantigen is a Potent Booster for Dendritic Cell Vaccines in Cancer Immunotherapy.

|Feb 27, 2026
Opportunities and challenges for cancer immunotherapy based on antigen cross-presentation.

Peng Liu, Zhe Zhou, Xiaoqiu Su

|Dec 02, 2025
PROTAC-based nanoantigens promote cross-presentation and trafficking of dendritic cell vaccine for enhanced antitumor efficacy.

Peng Liu, Zhe Zhou, Yijie Li

Pageof 1

Frequent Collaborators

3 joint publications

Jinyao Li

2 joint publications

Yuekang Xu

1 joint publications

Qiang Chen